Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ESPR | Esperion Therapeutics, Inc. | Aisling Capital II LP | 10% Owner | Apr 23, 2015 | Sale | $109.10 | 150,000 | 16,365,000 | 1,904,594 | Apr 27, 2015, 06:33 PM | |
ESPR | Esperion Therapeutics, Inc. | Aisling Capital II LP | 10% Owner | Apr 24, 2015 | Sale | $106.26 | 67,469 | 7,169,373 | 1,898,851 | Apr 27, 2015, 06:33 PM | |
ADMA | ADMA BIOLOGICS, INC. | Aisling Capital II LP | 10% Owner | Oct 22, 2013 | Buy | $8.50 | 411,765 | 3,500,003 | 3,620,143 | Oct 23, 2013, 04:25 PM | |
ESPR | Esperion Therapeutics, Inc. | Aisling Capital II LP | 10% Owner | Jul 01, 2013 | Buy | $14.00 | 1,428,714 | 20,001,996 | 2,054,594 | Jul 01, 2013, 04:33 PM | |
CEMP | CEMPRA, INC. | Aisling Capital II LP | 10% Owner | Feb 07, 2012 | Buy | $6.00 | 1,213,663 | 7,281,978 | 3,293,060 | Feb 09, 2012, 12:33 PM |